Status:
COMPLETED
Motivating Occupational Virtual Experiences In Therapy for Kids
Lead Sponsor:
Barron Associates, Inc.
Collaborating Sponsors:
University of Virginia
Duke University
Conditions:
Virtual Reality
Occupational Therapy
Eligibility:
All Genders
4-14 years
Phase:
NA
Brief Summary
A rater-blinded randomized controlled trial (RCT) will be conducted to compare the efficacy of MOVE-IT use in a remotely supervised home exercise program (HEP) to usual care for recovery of upper extr...
Detailed Description
A rater-blinded randomized controlled trial (RCT) will be conducted to compare the efficacy of MOVE-IT use in a remotely supervised home exercise program (HEP) to usual care for recovery of upper extr...
Eligibility Criteria
Inclusion
- Diagnosis of hemiplegia resulting from cerebral palsy, stroke, or other form of brain injury;
- Medically stable;
- Participant has antigravity strength in the affected UE at the elbow to at least 45 degrees of active flexion;
- Participant has antigravity shoulder strength in the affected UE to at least 30 degrees each in active flexion, abduction/adduction, and 15 degrees in active internal/external rotation when in an upright and seated position;
- Participant has ability to perform a basic color-matching test and identify characters on a vision chart;
- Participant must be available to attend study visits during an approximately 3-week participation period;
- Willingness and ability to comply with scheduled visits and study procedures.
Exclusion
- History of uncontrolled seizures;
- Has received another form of intensive UE therapy, such as CIMT, within the prior 6 months;
- Unwillingness or inability to understand or follow verbal directions;
- Diagnosis of moderate to severe cortical-visual impairment that in the judgement of the Principal Investigator could adversely impact the subject's participation;
- Psychological diagnosis that in the determination of the Principal Investigator could significantly impact subject's participation or that could be aggravated by study participation;
- Determination that participation would result in over exertion, or significant discomfort or pain;
- Determination that participation would result in significant agitation or elevated stress;
- Visual field deficit in either eye that impairs the ability to view the computer monitor.
Key Trial Info
Start Date :
June 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04510857
Start Date
June 17 2022
End Date
June 15 2024
Last Update
October 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University
Durham, North Carolina, United States, 27705
2
University of Virginia (UVA)
Charlottesville, Virginia, United States, 22908